Literature DB >> 30990251

Crime and victimization among people with intellectual disability with and without comorbid mental illness.

Stuart D M Thomas1,2, Margaret Nixon3, James R P Ogloff3,4, Michael Daffern3,4.   

Abstract

BACKGROUND: Accumulating evidence internationally points to an increased risk of crime perpetration and victimization among people with an intellectual disability (ID). This study aimed to examine the impact that comorbid mental illness had on the association between intellectual disability, crime perpetration and criminal victimization.
METHOD: A case linkage methodology involving 2,220 individuals with an intellectual disability from an Australian State.
RESULTS: One in four (27%) had contacts with public mental health services; 8.2% had a comorbid mental illness. This "dual disability" group was between 2.97 and 3.22 times more likely than those with intellectual disability alone to have a history of criminal charges, and between 2.76 and 2.97 times more likely to have been a victim of crime.
CONCLUSIONS: The extent of criminality and victimization found among people with dual disability indicates a potentially multiply stigmatized group for whom the need for a coordinated cross-agency service response remains paramount.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  comorbid mental illness; crime; dual disability; learning disability; stigma; victimization

Year:  2019        PMID: 30990251     DOI: 10.1111/jar.12598

Source DB:  PubMed          Journal:  J Appl Res Intellect Disabil        ISSN: 1360-2322


  2 in total

1.  Risk Factors for Sexual Offenses Committed by Men With or Without a Low IQ: An Exploratory Study.

Authors:  Audrey Vicenzutto; Christian C Joyal; Émilie Telle; Thierry H Pham
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

2.  Exploring the victim offender overlap among people with an intellectual disability.

Authors:  Sophie Anstis; Stuart D M Thomas
Journal:  J Appl Res Intellect Disabil       Date:  2022-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.